Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for ...

Eli LillyDemand for weight-loss drugs in India has shot up.And rivals Novo Nordisk and Eli Lilly are battling for market ...

Incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst ...

The incidence of obesity and diabetes is rising in India, the world’s most populous country, which also ranks among the worst ...

The demand for weight-loss medications is rapidly increasing in India, with competitors Eli Lilly and Novo Nordisk vying for ...

Sales of anti-obesity drugs like Mounjaro and Wegovy are seeing a jump due to a surge in popularity, Business Standard ...

Sales of anti-obesity drugs like Mounjaro and Wegovy are seeing a jump due to a surge in popularity, Business Standard ...

According to Pharmarack data, as cited by Reuters, Eli Lilly’s Mounjaro, which launched in India in late March 2025, has seen remarkable sales momentum. The company sold 87,986 units in June ...

The demand for obesity drugs in India is surging as Eli Lilly and Novo Nordisk compete. A Pakistani startup sends prosthetics ...